Please login to the form below

Not currently logged in

More impressive data from Bluebird’s gene therapy in thalassemia and sickle cell disease


Cell and gene therapy specialist Bluebird going head-to-head with partner Celgene

British Business Bank sets up £2.5bn fund for ‘unicorn’ firms

UK government says the private sector will bring in another £5bn in investments

Eisai to tackle dementia in new US research facility

Eisai EMEA DubaiAims to introduce a new compound into the clinic by 2020

Jim Mellon's biotech Juvenescence raises $50m for anti-ageing therapies

Jim MellonBillionaire's belief in emerging anti-ageing therapies fuels start up

Daily Brief: PRIME status for vaccine, NHS urged to adopt automation, Brexit votes loom

EMAA rapid round up of pharma, biotech and healthcare news

Gates’ non-profit biotech for poverty diseases sets out its stall at BIO

GatesMRIChief executive Heaton says GatesMRI will be a place where translational science meets medicine

Off BACE: AZ/Lilly drop Alzheimer’s drug lanabecestat

Alzheimer's disease brain scanAnother BACE candidate is abandoned, leaving just one remaining in the pipeline

Cancer Research UK to test Asterias’ lung cancer vaccine

Cancer Research UK logoThe vaccine could treat NSCLC patients who are at risk of relapse

UK pharma cheers EU science announcement

EU flagUK won't be excluded from Horizon research collaboration

clusterAdopting a creative IP approach towards biotech clusters

Why big pharma paradigm needs to change

Featured jobs

Subscribe to our email news alerts


Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Australian Flu and the dilemma of naming diseases
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....